Guillaume BENOIT

Guillaume Benoit is a Senior Research Scientist specializing in Synthetic and Medicinal Chemistry at AstraZeneca. They previously worked as a Scientist at Paraza Pharma Inc., focusing on medicinal chemistry and the design of synthetic routes for biologically active molecules. Guillaume earned a Ph.D. in Organic Chemistry from the University of Montreal, where they developed innovative methods in borocyclopropanation. Their research experience includes positions at various institutions, including internships at AstraZeneca and CERMN, where they contributed to the synthesis of novel kinase inhibitors.